Silicon Laboratories (SLAB)
NASDAQ:SLAB
Want to see SLAB full AI Analyst Report?
Top Page
Silicon Laboratories
(NASDAQ:SLAB)
Select Model
Select Model
Rating:66Neutral
Price Target:
$232.00
▲(8.98% Upside)
Action:ReiteratedDate:04/25/26
The score is driven primarily by improving financials and a de-risked, near debt-free balance sheet with positive TTM cash generation, offset by continued net losses and uneven cash-flow history. Technicals are supportive (strong uptrend) but look overbought, while valuation remains a key weakness due to negative earnings. The TI acquisition announcement is a notable positive corporate catalyst that supports the overall profile.
Positive Factors
Balance Sheet Strength
Minimal leverage and a sizable equity base provide durable financial flexibility. Low debt reduces refinancing and interest-rate risk, enabling sustained R&D, potential bolt-on M&A, and support through semiconductor cycles without forcing near-term capital raises that could dilute long-term strategy.
Negative Factors
Persistent Operating Losses
Ongoing operating losses constrain the company's ability to generate returns for shareholders and indicate core profitability issues. Until operating margins sustainably flip positive, earnings power and internal funding for expansion remain limited, increasing sensitivity to cost or revenue shocks.
Read all positive and negative factors
Positive Factors
Negative Factors
Balance Sheet Strength
Minimal leverage and a sizable equity base provide durable financial flexibility. Low debt reduces refinancing and interest-rate risk, enabling sustained R&D, potential bolt-on M&A, and support through semiconductor cycles without forcing near-term capital raises that could dilute long-term strategy.
Read all positive factors
Silicon Laboratories (SLAB) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$7.07B
Dividend YieldN/A
Average Volume (3M)382.52K
Price to Earnings (P/E)―
Beta (1Y)1.46
Revenue Growth47.10%
EPS Growth64.29%
CountryUS
Employees1,889
SectorTechnology
Sector Strength88
IndustrySemiconductors
Share Statistics
EPS (TTM)0.56
Shares Outstanding32,968,414
10 Day Avg. Volume299,560
30 Day Avg. Volume382,519
Financial Highlights & Ratios
PEG Ratio1.00
Price to Book (P/B)3.94
Price to Sales (P/S)5.50
P/FCF Ratio65.62
Enterprise Value/Market Cap0.95
Enterprise Value/Revenue8.59
Enterprise Value/Gross Profit14.75
Enterprise Value/Ebitda-353.31
Forecast
1Y Price Target
$222.86Price Target Upside4.68% Upside
Rating ConsensusHold
Number of Analyst Covering10
EPS Forecast (FY)2.71
Revenue Forecast (FY)$926.83M
Silicon Laboratories Business Overview & Revenue Model
Company Description
Silicon Laboratories Inc., a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, and internationally. The company's products include wireless microcontrollers and sensor products. It...
How the Company Makes Money
Silicon Labs primarily makes money by selling semiconductor products (fabless ICs) used in IoT end devices, with revenue recognized from shipments to customers through a mix of direct sales and channel partners/distributors. The core revenue strea...
Silicon Laboratories Key Performance Indicators (KPIs)
Silicon Laboratories Earnings Call Summary
Earnings Call Date:Nov 04, 2025
(Q3-2025)
| % Change Since: |
Next Earnings Date:Apr 29, 2026
Earnings Call Sentiment Positive
Silicon Labs reported strong revenue growth and improved gross margins, driven by strategic execution and innovation in IoT. However, some challenges remain with customer inventory levels and sustainable gross margins. Overall, the company's outlook remains positive with expectations for continued market share gains.Positive Updates
Strong Revenue Growth
Silicon Labs expects full-year revenue growth of 34% compared to 2024, with a diverse set of industrial applications driving a 7% sequential increase to $206 million in the September quarter.
Negative Updates
Onetime Benefit in Gross Margin
The December quarter includes an expected onetime benefit to gross margins, which adds approximately 200 basis points, indicating that current gross margins may not be sustainable long-term.
Read all updates
Q3-2025 Updates
Positive
Negative
Strong Revenue Growth
Silicon Labs expects full-year revenue growth of 34% compared to 2024, with a diverse set of industrial applications driving a 7% sequential increase to $206 million in the September quarter.
Read all positive updates
Company Guidance
In the Silicon Labs Third Quarter Fiscal 2025 Conference Call, the company provided robust guidance and an optimistic outlook based on their recent financial performance. For the full year, they anticipate a 34% revenue growth compared to 2024, driven by strong demand in industrial and commercial sectors and a significant uptick in smart meter and medical applications. In Q3, revenue reached $206 million, a 7% sequential increase, and a 24% rise year-over-year. They project Q4 revenue between $200 million and $215 million, with gross margins expected to expand to 62%-64%. This margin increase incorporates a one-time benefit contributing about 200 basis points. Additionally, the company forecasted a non-GAAP operating expense range of $110 million to $112 million and anticipated non-GAAP earnings per share of $0.40 to $0.70. They highlighted strategic innovations like the Studio 6 enablement platform and Simplicity AI SDK, which are expected to accelerate IoT market penetration and drive long-term growth.Silicon Laboratories Financial Statement Overview
Summary
Income Statement
46
Neutral
Balance Sheet
82
Very Positive
Cash Flow
64
Positive
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 784.76M | 584.39M | 782.26M | 1.02B | 720.86M |
| Gross Profit | 456.98M | 312.19M | 460.59M | 642.56M | 425.39M |
| EBITDA | -18.85M | -104.92M | 46.09M | 189.77M | 35.41M |
| Net Income | -64.91M | -191.01M | -34.52M | 91.40M | 2.12B |
Balance Sheet | |||||
| Total Assets | 1.27B | 1.22B | 1.44B | 2.17B | 2.96B |
| Cash, Cash Equivalents and Short-Term Investments | 443.62M | 382.16M | 439.22M | 1.19B | 2.04B |
| Total Debt | 0.00 | 21.43M | 64.83M | 547.58M | 450.60M |
| Total Liabilities | 174.90M | 142.65M | 234.37M | 764.42M | 745.87M |
| Stockholders Equity | 1.09B | 1.08B | 1.21B | 1.41B | 2.21B |
Cash Flow | |||||
| Free Cash Flow | 65.79M | -25.66M | -52.63M | 45.28M | -129.02M |
| Operating Cash Flow | 95.71M | -13.91M | -30.35M | 71.81M | -100.44M |
| Investing Cash Flow | -12.03M | 113.12M | 469.81M | 240.54M | 2.27B |
| Financing Cash Flow | -1.07M | -45.10M | -711.87M | -887.05M | -1.30B |
Silicon Laboratories Technical Analysis
Positive
212.89
Price Trends
206.46
Positive
173.20
Positive
153.47
Positive
Market Momentum
3.07
Positive
78.62
Negative
91.99
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SLAB, the sentiment is Positive. The current price of 212.89 is above the 20-day moving average (MA) of 209.10, above the 50-day MA of 206.46, and above the 200-day MA of 153.47, indicating a bullish trend. The MACD of 3.07 indicates Positive momentum. The RSI at 78.62 is Negative, neither overbought nor oversold. The STOCH value of 91.99 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SLAB.
Silicon Laboratories Risk Analysis
Silicon Laboratories disclosed 42 risk factors in its most recent earnings report. Silicon Laboratories reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Silicon Laboratories Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
83 Outperform | $8.81B | 10.99 | 20.13% | ― | 2.19% | 19.22% | |
77 Outperform | $14.54B | 59.58 | 6.85% | ― | 6.38% | -4.15% | |
66 Neutral | $7.07B | -66.51 | -6.05% | ― | 47.10% | 64.29% | |
66 Neutral | $18.07B | 26.10 | 8.73% | 0.81% | 0.13% | -16.17% | |
66 Neutral | $9.79B | -177.61 | -7.22% | ― | 20.60% | ― | |
66 Neutral | $8.08B | 149.88 | -1.40% | ― | -7.23% | -15.69% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |
* Technology Sector Average
SLAB
Silicon Laboratories
215.50
112.88
110.00%
AMKR
Amkor
78.10
60.82
352.10%
CRUS
Cirrus Logic
174.17
80.50
85.95%
ONTO
Onto Innovation
307.86
183.13
146.82%
SMTC
Semtech
109.79
79.86
266.82%
ALGM
Allegro MicroSystems
44.13
24.90
129.49%
Silicon Laboratories Corporate Events
Executive/Board ChangesShareholder Meetings
Silicon Labs Shareholders Approve Directors and Executive Compensation
Positive
Apr 24, 2026
At its April 23, 2026 Annual Meeting of Stockholders, Silicon Laboratories shareholders re-elected Class I directors Navdeep S. Sooch and Nina Richardson to the board, affirming the company’s existing leadership structure. Investors also str...
Business Operations and StrategyM&A Transactions
Silicon Labs Signs $7.5B TI Acquisition Deal
Positive
Feb 4, 2026
On February 4, 2026, Silicon Labs announced it had entered into a definitive agreement to be acquired by Texas Instruments in an all-cash transaction valuing the company at approximately $7.5 billion, or $231 per share, with closing expected in th...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.